Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
18.64
-0.66 (-3.42%)
At close: May 22, 2026, 4:00 PM EDT
19.05
+0.41 (2.20%)
After-hours: May 22, 2026, 7:58 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.96 billion as of May 22, 2026. Its market cap has increased by 41.12% in one year.
Market Cap
2.96B
Enterprise Value
1.95B
1-Year Change
41.12%
Ranking
Category
Stock Price
$18.64
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.96B, an increase of 56.76%. That is a compound annual growth rate of 5.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.96B | 22.17% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.22B |
| Relay Therapeutics | 2.95B |
| Arcus Biosciences | 2.95B |
| Tango Therapeutics | 2.93B |
| Dyne Therapeutics | 2.87B |
| Beam Therapeutics | 2.85B |
| Alumis | 2.81B |
| Structure Therapeutics | 2.79B |